A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin.
Harris
A M
AM
Microbiology Division, Glaxo Group Research Ltd., Greenford, Middlesex, England.
Plested
S J
SJ
Harper
P B
PB
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects* / Q000201:enzymology; D002442:Ceftazidime / Q000494:pharmacology*; D002511:Cephalosporins / Q000494:pharmacology*; D005839:Gentamicins / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D011549:Pseudomonas / Q000187:drug effects; D001618:beta-Lactamases / Q000378:metabolism
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D005839:Gentamicins; D002442:Ceftazidime; D001618:beta-Lactamases